学术探索
学术期刊
新闻热点
数据分析
智能评审

Glycosylated hemoglobin levels and clinical outcomes in diabetic patients receiving percutaneous coronary interventions: A meta-analysis of cohort studies

被引：5
作者：
Xu, Xiang [1 ]
Wang, Robin [2 ]
Wang, Yangang [2 ]
Cai, Shanglang [1 ]
机构：
[1] Qingdao Univ, Affiliated Hosp, Dept Cardiol, Qingdao 266003, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao 266003, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 190卷
关键词：
Percutaneous coronary interventions; Glycosylated hemoglobin; Major advance cardiovascular events; Diabetes mellitus; IN-STENT RESTENOSIS; GLYCEMIC CONTROL; GLYCATED HEMOGLOBIN; MORTALITY; MELLITUS; IMPACT; REVASCULARIZATION; ASSOCIATION; SINGLE; CANCER;
D O I：
10.1016/j.ijcard.2015.04.126
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：143 / 147
页数：5
相关论文
共 31 条
  • [1] Potential mechanisms promoting restenosis in diabetic patients
    Aronson, D
    Bloomgarden, Z
    Rayfield, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (03) : 528 - 535
  • [2] Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention
    Corpus, RA
    George, PB
    House, JA
    Dixon, SR
    Ajluni, SC
    Devlin, WH
    Timmis, GC
    Balasubramaniam, M
    O'Neill, WW
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) : 8 - 14
  • [3] Beyond restenosis - Five-year clinical outcomes from second-generation coronary stent trials
    Cutlip, DE
    Chhabra, AG
    Baim, DS
    Chauhan, MS
    Marulkar, S
    Massaro, J
    Bakhai, A
    Cohen, DJ
    Kuntz, RE
    Ho, KKL
    [J]. CIRCULATION, 2004, 110 (10) : 1226 - 1230
  • [4] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [5] REPRODUCIBILITY OF HEMOGLOBIN-ALC AND SENSITIVITY TO VARIOUS DEGREES OF GLUCOSE-INTOLERANCE
    DUNN, PJ
    COLE, RA
    SOELDNER, JS
    GLEASON, RE
    [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (03) : 390 - 396
  • [6] Effect of Baseline Glycemic Level on Long-Term Cardiovascular Outcomes After Coronary Revascularization Therapy in Patients With Type 2 Diabetes Mellitus Treated With Hypoglycemic Agents
    Ehara, Natsuhiko
    Morimoto, Takeshi
    Furukawa, Yutaka
    Shizuta, Satoshi
    Taniguchi, Ryoji
    Nakagawa, Yoshihisa
    Hoshino, Kozo
    Saito, Naritatsu
    Doi, Takahiro
    Haruna, Yoshisumi
    Ozasa, Neiko
    Imai, Yukiko
    Teramukai, Satoshi
    Fukushima, Masanori
    Kita, Toru
    Kimura, Takeshi
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (07) : 960 - 966
  • [7] Diabetes and coronary revascularization
    Flaherty, JD
    Davidson, CJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (12): : 1501 - 1508
  • [8] The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure -: An analysis of the Candesartan in Heart failure:: Assessment of Reduction in Mortality and Morbidity (CHARM) program
    Gerstein, Hertzel C.
    Swedberg, Karl
    Carlsson, Jonas
    McMurray, John J. V.
    Michelson, Eric L.
    Olofsson, Bertil
    Pfeffer, Marc A.
    Yusuf, Salim
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) : 1699 - 1704
  • [9] Quantifying heterogeneity in a meta-analysis
    Higgins, JPT
    Thompson, SG
    [J]. STATISTICS IN MEDICINE, 2002, 21 (11) : 1539 - 1558
  • [10] Hong LF, 2014, J GERIATR CARDIOL, V11, P245, DOI 10.11909/j.issn.1671-5411.2014.03.015
1234